1 Intensive Care Unit, Emergency department, Hospital das Clínicas, University of São Paulo Medical School, São Paulo, Brazil.
2 Intensive Care Unit, Hospital da Luz, Amil, São Paulo, Brazil.
J Intensive Care Med. 2019 Sep;34(9):714-722. doi: 10.1177/0885066617710914. Epub 2017 Jun 1.
Early initiation of renal replacement therapy (RRT) effect on survival and renal recovery of critically ill patients is still uncertain. We aimed to systematically review current evidence comparing outcomes of early versus late initiation of RRT in critically ill patients.
We searched the Medline (via Pubmed), LILACS, Science Direct, and CENTRAL databases from inception until November 2016 for randomized clinical trials (RCTs) or observational studies comparing early versus late initiation of RRT in critically ill patients. The primary outcome was mortality. Duration of mechanical ventilation, intensive care unit (ICU) length of stay (LOS), hospital LOS, and renal function recovery were secondary outcomes. Meta-analysis and trial sequential analysis (TSA) were used for the primary outcome.
Sixty-two studies were retrieved and analyzed, including 11 RCTs. There was no difference in mortality between early and late initiation of RRT among RCTs (odds ratio [OR] = 0.78; 95% confidence interval [CI]: 0.52-1.19; = 63.1%). Trial sequential analysis of mortality across all RCTs achieved futility boundaries at both 1% and 5% type I error rates, although a subgroup analysis of studies including only acute kidney injury patients was not conclusive. There was also no difference in time on mechanical ventilation, ICU and hospital LOS, or renal recovery among studies. Early initiation of RRT was associated with reduced mortality among prospective (OR = 0.69; 95% CI: 0.49-0.96; = 85.9%) and retrospective (OR = 0.61; 95% CI: 0.41-0.92; = 90.9%) observational studies, both with substantial heterogeneity. However, subgroup analysis excluding low-quality observational studies did not achieve statistical significance.
Pooled analysis of randomized trials indicates early initiation of RRT is not associated with lower mortality rates. The potential benefit of reduced mortality associated with early initiation of RRT was limited to low-quality observational studies.
关于起始肾脏替代治疗(RRT)时间对危重症患者的生存和肾功能恢复的影响,目前尚存争议。本研究旨在系统评价比较早期和晚期开始 RRT 对危重症患者的影响。
检索 Medline(通过 Pubmed)、LILACS、Science Direct 和 CENTRAL 数据库,时间从建库至 2016 年 11 月,纳入比较早期和晚期开始 RRT 对危重症患者影响的随机对照临床试验(RCT)和观察性研究。主要结局为死亡率。次要结局为机械通气时间、重症监护病房(ICU)住院时间(LOS)、医院 LOS 和肾功能恢复。主要结局采用 Meta 分析和试验序贯分析(TSA)。
共检索到 62 项研究,其中 11 项为 RCT。RCT 中早期和晚期开始 RRT 死亡率差异无统计学意义(OR=0.78,95%CI:0.52-1.19; =63.1%)。所有 RCT 的死亡率 TSA 在 1%和 5%的Ⅰ类错误率下均达到无效界值,但是仅纳入急性肾损伤患者的亚组分析结果尚无定论。机械通气时间、ICU 和医院 LOS、肾功能恢复等指标在研究之间也无差异。前瞻性(OR=0.69,95%CI:0.49-0.96; =85.9%)和回顾性(OR=0.61,95%CI:0.41-0.92; =90.9%)观察性研究中,早期开始 RRT 与死亡率降低相关,且具有统计学意义,但排除低质量观察性研究的亚组分析无统计学意义。
RCT 汇总分析显示,早期开始 RRT 与死亡率降低无关。早期开始 RRT 与死亡率降低相关的潜在获益仅局限于低质量的观察性研究。